Jain Global LLC Exits Position in Damora Therapeutics, Inc. (GLTO)

This Schedule 13G/A filing, dated May 15, 2026, indicates that Jain Global LLC, Jain Holdings LLC, and Robert Jain have fully exited their position in Damora Therapeutics, Inc. (formerly Galecto, Inc., ticker: GLTO). As of the event date on March 31, 2026, the reporting persons collectively reported beneficial ownership of zero shares, representing 0.0% of the company's common stock. Jain Global LLC served as the investment manager for the Jain Global Master Fund Ltd, which previously held the shares. Jain Holdings LLC is the sole member of Jain Global, and Robert Jain serves as the Chief Executive Officer and Chief Investment Officer. The filing serves as an amendment to their previous disclosure, confirming that they have ceased to be beneficial owners of more than five percent of the class of securities. The securities were originally held in the ordinary course of business and not for the purpose of influencing control of the issuer.